Preclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopes

Vaccine

Volumn 29, Issue 11, 2011, Pages 2110-2119

  Niu, Liguo ^a,d   Termini, James M ^a   Kanagavelu, Saravana K ^a   Gupta, Sachin ^a   Rolland, Morgane M ^b   Kulkarni, Viraj ^c   Pavlakis, George N ^c   Felber, Barbara K ^c   Mullins, James I ^b   Fischl, Margaret A ^a   Stone, Geoffrey W ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Dendritic cell; HIV; RNA; Therapeutic vaccination

Indexed keywords

DENDRITIC CELL VACCINE; EPITOPE; GAG PROTEIN; GAMMA INTERFERON; INTERLEUKIN 2; RNA;

ARTICLE; BLOOD SAMPLING; CD8+ T LYMPHOCYTE; CELL MATURATION; CELL THERAPY; CLINICAL ARTICLE; COCULTURE; COHORT ANALYSIS; CONTROLLED STUDY; EFFECTOR CELL; EX VIVO STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; IMMUNOTHERAPY; MEMORY T LYMPHOCYTE; MONOCYTE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL;

AIDS VACCINES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; INTERLEUKIN-2; RNA, VIRAL;

EID: 79951812694     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.12.131     Document Type: Article

References (33)

1. Kim S., Lee J.B., Lee G.K., Chang J. Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer. Prostate 2009, 69:938-948.
2. Higano C.S., Small E.J., Schellhammer P., Yasothan U., Gubernick S., Kirkpatrick P., et al. Sipuleucel-T. Nat Rev Drug Discov 2010, 9:513-514.
3. Gilboa E., Vieweg J. Cancer immunotherapy with mRNA-transfected dendritic cells. Immunol Rev 2004, 199:251-263.
4. Kavanagh D.G., Kaufmann D.E., Sunderji S., Frahm N., Le Gall S., Boczkowski D., et al. Expansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted. Nef Blood 2006, 107:1963-1969.
5. Routy J.P., Boulassel M.R., Yassine-Diab B., Nicolette C., Healey D., Jain R., et al. Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapy. Clin Immunol 2010, 134:140-147.
6. Van Gulck E.R., Vanham G., Heyndrickx L., Coppens S., Vereecken K., Atkinson D., et al. Efficient in vitro expansion of human immunodeficiency virus (HIV)-specific T-cell responses by gag mRNA-electroporated dendritic cells from treated and untreated HIV type 1-infected individuals. J Virol 2008, 82:3561-3573.
7. Van Tendeloo V.F., Van de Velde A., Van Driessche A., Cools N., Anguille S., Ladell K., et al. Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination. Proc Natl Acad Sci USA 2010, 107:13824-13829.
8. Rinaldo C.R. Dendritic cell-based human immunodeficiency virus vaccine. J Intern Med 2009, 265:138-158.
9. Nickle D.C., Rolland M., Jensen M.A., Pond S.L., Deng W., Seligman M., et al. Coping with viral diversity in HIV vaccine design. PLoS Comput Biol 2007, 3:e75.
10. Rolland M., Nickle D.C., Mullins J.I. HIV-1 group M conserved elements vaccine. PLoS Pathog 2007, 3:e157.
11. Liu Y., McNevin J., Rolland M., Zhao H., Deng W., Maenza J., et al. Conserved HIV-1 epitopes continuously elicit subdominant cytotoxic T-lymphocyte responses. J Infect Dis 2009, 200:1825-1833.
12. Rousseau C.M., Lockhart D.W., Listgarten J., Maley S.N., Kadie C., Learn G.H., et al. Rare HLA drive additional HIV evolution compared to more frequent alleles. AIDS Res Hum Retroviruses 2009, 25:297-303.
13. Rolland M., Carlson J.M., Manocheewa S., Swain J.V., Lanxon-Cookson E., Deng W., et al. Amino-acid co-variation in HIV-1 Gag subtype C: HLA-mediated selection pressure and compensatory dynamics. PLoS One 2010, 5:pii:e12463.
14. Leslie A.J., Pfafferott K.J., Chetty P., Draenert R., Addo M.M., Feeney M., et al. HIV evolution: CTL escape mutation and reversion after transmission. Nat Med 2004, 10:282-289.
15. Altfeld M., Addo M.M., Rosenberg E.S., Hecht F.M., Lee P.K., Vogel M., et al. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection. Aids 2003, 17:2581-2591.
16. Hendel H., Caillat-Zucman S., Lebuanec H., Carrington M., O'Brien S., Andrieu J.M., et al. New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. J Immunol 1999, 162:6942-6946.
17. Sabado R.L., O'Brien M., Subedi A., Qin L., Hu N., Taylor E., et al. Evidence of dysregulation of dendritic cells in primary HIV infection. Blood 2010, 116:3839-3852.
18. Chougnet C. Role of CD40 ligand dysregulation in HIV-associated dysfunction of antigen-presenting cells. J Leukoc Biol 2003, 74:702-709.
19. Boasso A., Shearer G.M. Chronic innate immune activation as a cause of HIV-1 immunopathogenesis. Clin Immunol 2008, 126:235-242.
20. Kaufmann D.E., Kavanagh D.G., Pereyra F., Zaunders J.J., Mackey E.W., Miura T., et al. Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction. Nat Immunol 2007, 8:1246-1254.
21. Paiardini M., Frank I., Pandrea I., Apetrei C., Silvestri G. Mucosal immune dysfunction in AIDS pathogenesis. Aids Rev 2008, 10:36-46.
22. Calarota S.A., Foli A., Maserati R., Baldanti F., Paolucci S., Young M.A., et al. HIV-1-specific T cell precursors with high proliferative capacity correlate with low viremia and high CD4 counts in untreated individuals. J Immunol 2008, 180:5907-5915.
23. Rehr M., Cahenzli J., Haas A., Price D.A., Gostick E., Huber M., et al. Emergence of polyfunctional CD8+ T cells after prolonged suppression of human immunodeficiency virus replication by antiretroviral therapy. J Virol 2008, 82:3391-3404.
24. Trautmann L., Janbazian L., Chomont N., Said E.A., Gimmig S., Bessette B., et al. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med 2006, 12:1198-1202.
25. Zhang D., Shankar P., Xu Z., Harnisch B., Chen G., Lange C., et al. Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic. Blood 2003, 101:226-235.
26. Buisson S., Benlahrech A., Gazzard B., Gotch F., Kelleher P., Patterson S. Monocyte-derived dendritic cells from HIV type 1-infected individuals show reduced ability to stimulate T cells and have altered production of interleukin (IL)-12 and IL-10. J Infect Dis 2009, 199:1862-1871.
27. Erikstrup C., Kronborg G., Lohse N., Rye Ostrowski S., Gerstoft J., Ullum H. T-cell dysfunction in HIV-1-infected patients with impaired recovery of CD4 cells despite suppression of viral replication. J Acquir Immune Defic Syndr 2010, 53:303-310.
28. Fuse S., Tsai C.Y., Molloy M.J., Allie S.R., Zhang W., Yagita H., et al. Recall responses by helpless memory CD8+ T cells are restricted by the up-regulation of PD-1. J Immunol 2009, 182:4244-4254.
29. Letvin N.L., Mascola J.R., Sun Y., Gorgone D.A., Buzby A.P., Xu L., et al. Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys. Science 2006, 312:1530-1533.
30. Mattapallil J.J., Douek D.C., Buckler-White A., Montefiori D., Letvin N.L., Nabel G.J., et al. Vaccination preserves CD4 memory T cells during acute simian immunodeficiency virus challenge. J Exp Med 2006, 203:1533-1541.
31. Precopio M.L., Betts M.R., Parrino J., Price D.A., Gostick E., Ambrozak D.R., et al. Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses. J Exp Med 2007, 204:1405-1416.
32. Mehal W.Z., Crispe I.N. TCR ligation on CD8+ T cells creates double-negative cells in vivo. J Immunol 1998, 161:1686-1693.
33. Subramanya S., Armant M., Salkowitz J.R., Nyakeriga A.M., Haridas V., Hasan M., et al. Enhanced induction of HIV-specific cytotoxic T lymphocytes by dendritic cell-targeted delivery of SOCS-1 siRNA. Mol Ther 2010, 18:2028-2037.